Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)

Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)

By screening an epigenetic compound library, we identified that UNC0638, a highly potent inhibitor of the histone methyltransferases G9a and GLP, was a weak inhibitor of SPIN1 (spindlin 1), a methyllysine reader protein. Our optimization of this weak hit resulted in the discovery of a potent, select...

Full description

Bibliographic Details
Main Authors:	Xiong, Y, Greschik, H, Johansson, C, Seifert, L, Bacher, J, Park, K, Babault, N, Martini, M, Fagan, V, Li, F, Chau, I, Christott, T, Dilworth, D, Barsyte-Lovejoy, D, Vedadi, M, Arrowsmith, C, Brennan, P, Fedorov, O, Jung, M, Farnie, G, Liu, J, Oppermann, U, Schüle, R, Jin, J
Format:	Journal article
Language:	English
Published:	American Chemical Society 2019

Similar Items

A chemical probe for Tudor domain protein spindlin1 to investigate chromatin function
by: Fagan, V, et al.
Published: (2019)

Identification of a small-molecule ligand of the epigenetic reader protein Spindlin1 via a versatile screening platform
by: Wagner, T, et al.
Published: (2016)

Recognition of dimethylarginine analogues by tandem Tudor domain protein Spindlin1
by: Porzberg, MRB, et al.
Published: (2022)

Bromo-deaza-SAH: A potent and selective DOT1L inhibitor
by: Yu, W, et al.
Published: (2013)

Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.
by: Yu, W, et al.
Published: (2013)

Investigations on small molecule inhibitors targeting the histone H3K4 tri-methyllysine binding PHD-finger of JmjC histone demethylases
by: Bhushan, B, et al.
Published: (2018)

Benzoisoquinolinediones as potent and selective inhibitors of BRPF2 and TAF1/TAF1L bromodomains
by: Bouché, L, et al.
Published: (2017)

PGV-1 is a potent antimitotic agent
by: Perpustakaan UGM, i-lib
Published: (2008)

Discovery of orally bioavailable, quinoline-based aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with potent cellular activity
by: Yang, S, et al.
Published: (2018)

PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2.
by: Schröder, R, et al.
Published: (2012)

Structural insights into interaction mechanisms of alternative piperazine-urea YEATS domain binders in MLLT1
by: Ni, X, et al.
Published: (2019)

Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
by: Zimmermann, T, et al.
Published: (2009)

Histone recognition and large-scale structural analysis of the human bromodomain family.
by: Filippakopoulos, P, et al.
Published: (2012)

MT1-MMP: a potent modifier of pericellular microenvironment.
by: Itoh, Y, et al.
Published: (2006)

7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.
by: Huber, K, et al.
Published: (2012)

Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3
by: Böttcher, J, et al.
Published: (2019)

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
by: Kim, H, et al.
Published: (2013)

Creation of a novel class of potent and selective MutT Homologue 1 (MTH1) inhibitors using fragment-based screening and structure-based drug design
by: Rahm, F, et al.
Published: (2018)

The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
by: Scherz-Shouval, Ruth, et al.
Published: (2016)

Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
by: Debdab, M, et al.
Published: (2011)

Looking glass inhibitors: synthesis of a potent naringinase inhibitor L-DIM [1,4-dideoxy-1,4-imino-L-mannitol], the enantiomer of DIM [1,4-dideoxy-1,4-imino-D-mannitol] a potent alpha-D-mannosidase inhibitor
by: Hakansson, A, et al.
Published: (2007)

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
by: Kim, H, et al.
Published: (2014)

Discovery of an MLLT1/3 YEATS domain chemical probe
by: Moustakim, M, et al.
Published: (2018)

Development of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye disease
by: Batson, J, et al.
Published: (2017)

Polyethyleneimine Is a Potent Mucosal Adjuvant and Candidate Adjuvant for HIV-1 Vaccination
by: Brinckmann, S, et al.
Published: (2011)

MC1R is a potent regulator of PTEN after UV exposure in melanocytes.
by: Cao, J, et al.
Published: (2013)

Potent inhibition of cartilage biosynthesis by coincubation with joint capsule through an IL-1-independent pathway
by: Grodzinsky, Alan J., et al.
Published: (2011)

Discovery of a selective inhibitor for the YEATS domains of ENL/AF9
by: Christott, T, et al.
Published: (2018)

Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance
by: Nalam, Madhavi N. L., et al.
Published: (2016)

Potent and selective α1A adrenoceptor partial agonists—Novel imidazole frameworks
by: Whitlock, G, et al.
Published: (2009)

Development of an open-source data analysis platform for high throughput screening in drug discovery and its application to E3 ligase IDOL inhibitor discovery project
by: Christott, T
Published: (2024)

New synthetic seven-membered 1-azasugars displaying potent inhibition towards glycosidases and glucosylceramide transferase.
by: Li, H, et al.
Published: (2008)

Potent antimalarial 2-Pyrazolyl Quinolone bc 1 (Qi) inhibitors with improved drug-like properties
by: Hong, W, et al.
Published: (2018)

Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex
by: Ivanochko, D, et al.
Published: (2018)

Bromodomain inhibitors are potent epigenetic regulators of catabolic gene expression in human osteoarthritic chondrocytes
by: Andres, d, et al.
Published: (2018)

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family.
by: Bataille, C, et al.
Published: (2017)

Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors.
by: Beswick, P, et al.
Published: (2004)

Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.
by: Hewings, D, et al.
Published: (2013)

DESIGN SYNTHESIS AND PRELIMINARY EVALUATION OF A POTENT ALPHA-MANNOSIDASE INHIBITOR - 1,4-DIDEOXY-1,4-IMINO-D-MANNITOL
by: Fleet, G, et al.
Published: (1984)

Scc2 is a potent activator of Cohesin’s ATPase that promotes loading by binding Scc1 without Pds5
by: Petela, N, et al.
Published: (2018)